ADAMS-1 and ADAMS-9, novel markers in endometriosis
| dc.authorid | 0000-0002-0093-2743 | en_US |
| dc.contributor.author | Hişmioğulları, Adnan Adil | |
| dc.contributor.author | Güney, Gürhan | |
| dc.contributor.author | Taşkın, Mine İslimye | |
| dc.contributor.author | Güngörmüş, Berna | |
| dc.date.accessioned | 2022-02-17T10:32:00Z | |
| dc.date.available | 2022-02-17T10:32:00Z | |
| dc.date.issued | 2021 | en_US |
| dc.department | Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
| dc.department | Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
| dc.description.abstract | Objectives: ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin repeats) proteinases, which are released outside the cell (soluble) have very critical roles in damage and repair of extracellular matrix (ECM) processes. Our aim was to analyse the ADAMTS-1 and ADAMTS-9 which were the member of the ADAMTS gene family of metalloproteinases that might had been involved in the cytokines-mediated etiopathogenesis of endometriosis. Methods: A case-control study was performed in an university hospital. Thirty-four patient with endometriosis which was defined via laparoscopy and thirty-three healthy female volunteers were recruited in the present study. Serum ADAMTS-1 and ADAMTS-9 and IL-beta (IL-1 β) and vascular endothelial growth factor (VEGF) levels were determined by a human enzyme-linked immunoassay (ELISA) in all subjects. Results: The demographic characteristics of the patients were significantly higher than healthy control group. The IL-1 β and VEGF levels were significantly higher; ADAMTS-1 and ADAMTS-9 levels were significantly lower in the endometriosis patients compared to the controls. We also found a negative correlation between ADAMTS-1, ADAMTS-9, and IL-1 β, VEGF. Conclusion: The results of the study might suggest that ADAMS-1 and ADAMTS-9 have a role in the pathogenesis of the endometriosis. | en_US |
| dc.description.sponsorship | Balikesir University 2015/222 | en_US |
| dc.identifier.doi | 10.1177/2284026520987915 | |
| dc.identifier.endpage | 126 | en_US |
| dc.identifier.issn | 2284-0265 | |
| dc.identifier.issn | 2284-0273 | |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.scopus | 2-s2.0-85099966646 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 122 | en_US |
| dc.identifier.uri | https://doi.org/10.1177/2284026520987915 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12462/12010 | |
| dc.identifier.volume | 13 | en_US |
| dc.identifier.wos | WOS:000609779800001 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | en_US |
| dc.publisher | Sage | en_US |
| dc.relation.ispartof | Journal of Endometriosis and Pelvic Pain Disorders | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
| dc.subject | Endometriosis | en_US |
| dc.subject | ADAMTS-1 | en_US |
| dc.subject | ADAMTS-9 | en_US |
| dc.subject | IL-1 β | en_US |
| dc.subject | VEGF | en_US |
| dc.title | ADAMS-1 and ADAMS-9, novel markers in endometriosis | en_US |
| dc.type | Article | en_US |












